Summary
A young man who had suffered several episodes of deep-vein thrombosis of the legs since the age of 20 had a myocardial infarction at the age of 33, at which time both a prolonged partial thromboplastin time (PTT), compatible with a lupus anticoagulant (LA), and decreased fibrinolytic capacity (FC) were found.
His sister presented with deep-vein thrombosis of a leg and subsequent pulmonary embolism when she was 18 years old. She had a miscarriage three years later and developed a hemolytic-uremic syndrome at the age of 35. The PT and FC were normal. Laboratory investigations of the parents revealed positive antinuclear antibodies in the mother's serum but no anomaly in the father.
This study suggests a familial tendency to develop autoimmune disorders associated with LA and thromboembolic complications related to decreased FC.
Similar content being viewed by others
Abbreviations
- PTT:
-
Partial thromboplastin time
- FC:
-
Fibrinolytic capacity
- LA:
-
Lupus anticoagulant
- TT:
-
Thrombin time
- PT:
-
Prothrombin time
- GPL:
-
Anticardiolipin antibodies IgG type
- MPL:
-
Anticardiolipin antibodies IgM type
- PC/FII:
-
Protein C/Factor II
- PC/FX:
-
Protein C/Factor X
- FII:
-
Factor II
- FX:
-
Factor X
References
Anonymous (1984) Lupus anticoagulant. Lancet 26:1157–1158
Arnett FC, Schulmann LE (1976) Studies in familial systemic lupus erythematosus. Medicine 55:313–322
Bloom EJ, Abrams DI, Rodgers G (1986) Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 256:491–493
Brown JH, Doherty CC, Allen DC, Morton P (1988) Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. Br Med J 296:1505
Byron MA, Cederholm-Williams SA (1987) Detection of antibodies to vascular endothelium: a possible contribution to thrombosis. Fibrinolysis 1:241–245
Canoso RT, Sise HS (1982) Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol 13:121–129
Colaco CB, Elkon KB (1985) The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum 28:67–74
Colman RW, Hirsh J, Marder VJ, Salzman EW (1987) In: Hemostasis and thrombosis. Basic principles and clinical practice, 2nd edn. Lippincott, Philadelphia, pp 832–840
Conley CL, Hartmann RC (1952) Hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31:621–622
Elias M, Eldor A (1984) Thromboembolism in patients with the “lupus”-type circulating anticoagulant. Arch Intern Med 144:510–515
Exner T, Barber S, Kronenberg H, Rickard KA (1980) Familial association of the lupus anticoagulant. Br J Haematol 45:89–96
Farquharson RG, Pearson JF, John L (1984) Lupus anticoagulant and pregnancy management. Lancet 1:228–229
Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJW (1985) Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 19:265–275
Grimaudo V, Hauert J, Bachmann F, Kruithof EKO (1988) Diurnal variation of the fibrinolytic system. Thromb Haemostas 59:495–499
Harris EN, Gharavi AE, Patel SP, Hughes GRV (1987) Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215–222
Laurell AB, Nilsson IM (1957) Hypergammaglobulinemia circulating anticoagulant and biologic false positive Wassermann reaction. J Lab Clin Med 49:694–707
Lechner K, Pabinger-Fasching I (1985) Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 15:254–262
Lechner K (1987) Lupus anticoagulants and thrombosis. In: Verstraete M, Vermylen J, Lijnen HR, Arnout J (eds) Thrombosis and haemostasis. Leuven University Press, pp 525–547
Lubbe WF, Butler WS, Palmer SS, Liggins GC (1984) Lupus anticoagulant in pregnancy. Br J Obst Gynaecol 91:357–363
Stafford-Brady FJ, Gladman DD, Urowitz MB (1988) Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant. Arch Intern Med 148:1647–1648
Tan EM, Cohen AS, Fries JF, Masi AT, Mac Shane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Triplett DA, Brandt JT, Musgrave KA, Orr CA (1988) The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 259:550–554
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jolidon, R.M., Knecht, H., Humair, L. et al. Different clinical presentations of a lupus anticoagulant in the same family. Klin Wochenschr 69, 340–344 (1991). https://doi.org/10.1007/BF02115779
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02115779